Upload
lamnga
View
221
Download
1
Embed Size (px)
Citation preview
ANNALS O F CLINICAL AND LABORATORY SCIEN CE, Vol. 21, No. 4Copyright © 1991, Institute for Clinical Science, Inc.
Maternal Hypothyroxinemia: Psychoneurological Deficits of Progeny*!
EVELYN B. MAN, Ph .D .,Î JAMES F. BROWN, M.D..§ and SALLY A. SERUNIAN, M.S."1f
tYale University School o f Medicine, New Haven, CT
Thyroid Laboratory o f Providence Lying-In Hospital, and Institute o f Health Science, Brown University (retired)
Providence, RI and
§Department o f Pediatrics, Westerly Hospital
Westerly, RI 02891 and
11Department o f Psychology, Brown UniversityProvidence, RI
and11Portland Public Schools, Portland, ME 04103
ABSTRACTM aternal thyroid function was evaluated clinically, by reproductive his
tory, and by serial m easurem ents of serum butanol-extractable iodine (thyroxine-like iodine), two before and two after 24 gestational weeks during 1,349 pregnancies. Three percent of the women were hypothyroxinémie. Developm ental, intellectual, and motor abilities of progeny born to (Group I) 210 euthyroxinemic, (Group II) 15 hypothyroxinémie given adequate thyroid replacem ent therapy, and (Group III) 21 inadequately treated hypothyroxinémie women were compared. The groups of mothers exhibited no significant differences in in telligence, years of education, or chronological age. Mean developm ental and intellectual scores at eight months, four and seven years of Group II progeny evidenced remarkably consistent similarity to scores of siblings and controls. At each age, mean developm ental and intellectual scores were lower for Group III progeny, and motor scores of the latter were lowest. Some progeny of Group II mothers, treated only after 12 or 29 weeks, failed the ball catch and line walk tests; some had strabismus and other ocular disturbances. Could these deficits have originated w ith m aternal hypothyroxinem ia during first sem ester weeks before the thyroid-pituitary axis matures? Now in 1990—1991, early findings fit into the modern concepts of significant maternal gestational transfer of thyroxine to the fetus. The authors encourage prenatal and/or early gestational screening for maternal hypothyroxinemia and urge prescription of adequate thyroid replacem ent therapy for hypothyroxiném ie women.
* P re se n ted a t th e Sem inar on L aboratory D iagnosis o f D isorders o f th e F e tus, N ew born , an d E arly C h ildhood , A ssociation o f C lin ical Scientists, C incinnati, O H , N ovem ber 7—11, 1990.
t Send re p rin t req u ests to E velyn B. M an, Ph.D ., 275 S teele Road, Apt. B407, W est H artford, C T 06117.
2270091-7370/91/0700-0227 $02.00 © Institute for Clinical Science, Inc.
228 MAN, BROWN, AN D SERUNIAN
Preface
Presentations of Dr. Gabriella Morre- ale de Escobar at several international symposia on congenital hypothyroidism a n d d a ta o f o th e r p e d ia t r ic en d o - crino log ists5,14’17’18,22’24’30’31’35 stim ula ted th is review . She em phasized a “once-and-only”30(p37) period for developm ent of the mammalian brain. During the most active phase of brain growth and differentiation, adequate amounts of thyroid hormones are essential for sequences of m aturational changes. Fetal production o f thyro id horm ones is major in d irecting brain developm ent, although recent evidence points to the need for m aternal euthyroidism. The tim etable for arrival of neurons, their m ultiplication and differentiation, the formation of glial cells, and m yelinogenesis may vary in d iffe re n t reg ions o f th e b ra in .30(p29) E ither a deficiency or an excess of thyroid horm ones at certain hours of the tim etable may change cell differentiation. W ithout the organizing effect of thyroid horm ones, portions o f the brain “grow into a tangled mass of poorly insulated, poorly connected neurofil.”30(p45)
Stages of developm ent of the human central nervous system (CNS) before 10, 12, or 14 weeks are dependent on thyroid horm ones. In reference to iodized oil injections, M orreale wrote, “Treatm ent before p regnancy or d u rin g the first trim este r appears to be necessary to eradicate neurological cretinism .”30 The ro le o f m a te rn a l th y ro x in e for fetal CNS d e v e lo p m e n t is re in fo rc e d by quotes from Thyroid. A Special Issue Dedicated to Life and Achievem ents o f Dr. Sidney H. Ingbar, with these quotes from Schussler.39
“Although early studies indicated that the free T4 might be low in pregnancy, it is probably normal in the second and third trimesters and somewhat elevated in the first trim ester.40”39<p27)
“ T here is increasing ev idence that physio logically sign ifican t en tities of thyroid horm one are transferred from th e m a te rn a l to th e fe ta l c i r c u la tion.44’45”39^
“As pointed out by Ekins,9 a maternal source of thyroid hormone is likely to be of greatest importance before fetal thyroid horm one secretion begins. Thus, the hC G -dependent increases of maternal T4 and T3 in the firs t trim este r may be of physiologic significance to the fetus. ”39(p28)
The importance of thyroid hormones for developm ent of the CNS during the first trim ester of hum an gestation and the role of maternal thyroxine for fetal brain developm ent become apparent.
Introduction
The actual data that three percent of w om en in 1,349 p re g n a n c ie s w ere hypothyroxinémie, and that some progeny of inadequately treated hypothyroxinémie women had low IQs and neuropsychological deficits were reported in10 papers published 1964 to 1976.27,28
Data on pregnancies of two groups of 375 wom en from 97 pregnancies were compared. Group I included 97 pregnanc ies o f 375 co n tro l e u th y ro x in em ic women. Group II included 97 pregnancies of 375 hypothyroxiném ie women. The incidence of abortions, prematurity, stillbirths, major anomalies, and offspring with subsequent retardation was 26 percent for the control women but 36 perc e n t for th e h y p o th y ro x in é m ie wo- m en.28(VI) N isw ander reported a high incidence of stillbirths of hypothyroid women.34 Recently, Lazarus and Walker began a w orldw ide survey o f the possib le relationship betw een various c o n g e n ita l an o m a lie s an d c o n g e n ital hypothyroidism.26
Some thyroidologists doubted our findings and kept repeating that thyroid hor
M ATERNAL HYPOTHYROXINEMIA: PSYCH ONEUROLOGICAL D E FIC IT S O F PROGENY 229m ones do not cross the placenta. The NATO Advanced Research Workshop on Congenital Hypothyroidism in Brussels, Belgium, May, 1988,14 and the study by Vulsma e t al in 198944 revolutionized the old w idely published hypothesis of placental im perm eability to thyroid hormones. Vulsma and coworkers dem onstrated that in late gestation considerable amounts of T4 are transferred from the m o th e r to h e r h y p o th y ro id fe tu s . L a r s e n 25 r e v ie w e d th e f in d in g s o f Vulsma and cohorts44 and referred to substan tia l tran sp lacen ta l passage of T4 w hen T4 cannot be synthesized by the fetal thyroid. Vulsma and coworkers dealt w ith cord serum and placental transfer of T4 to hypothyroids at term.44 Most new borns w ith congenital hypothyroidism and inability to synthesize T4 are asymptomatic at birth. This phenom enon has been assum ed to result from substantial placental transfer of m aternal T4 to the fetus during an appreciable length of gestation. The findings of Vulsma et al44 supported our data of 20 years ago. Even Fisher acknowledges that in humans thyroxine “clearly crosses the placenta.”20
Subjects and M ethods
The subjects in this longitudinal study were all participants in the Collaborative Perinatal Project of the National Institu te o f N e u ro lo g ic a l D ise a se s and Stroke.6’7,8’9,10,11 Prenatal examinations of euthyroxinemic and hypothyroxinémie gravidae w ere conducted at the Providence Lying-In Hospital from 1962 to 1967. M aternal thyroid function was evaluated clinically by reproductive history and by serial m easurem ents of serum butanol-extractable iodines (BEIs) (thyroxine-like iodine)28 two before and two after 24 gestational weeks during 1,349 pregnancies.28(I_IX) Women in the adequately treated hypothyroxinémie group had two low BEIs before 24 weeks and
thyroid replacem ent therapy* at a time interval begun at 12 or 29 gestational w eeks. W om en in th e in a d e q u a te ly trea ted hypothyroxinem ic group w ere those w ith two low BEIs but not given adequate replacem ent therapy. The original (1957) definition of serum iodine com pounds m easu red in th e B E I is as follows:27,28®
“ T o cla im th a t se rum B E I d e te rm in a tio n s are m ore p rec ise than PB I de term ina tions im p lies that th e exact chem ical n a tu re o f th e organic iod ine com p o u n d s in c lu d e d in m ea su re m e n t o f th e B E I is m ore accurate ly d e lin e a ted than is th e n a tu re o f th e iod ine com pounds p rec ip ita ted w ith p ro te in . “ T h y rox ine-like” (1, 6, 9) is th e b e s t desc rip tio n o f th e organic io d in e com pounds w hich a re in c lu d ed in B E I m easu rem en ts, in sp ite o f the resu lts o f recen t investigations o f analogues o f thyrox ine an d in v estig a tio n s o f th y ro x in e -b in d in g to p ro te in s (16). R ecoveries o f io d in e from thy rox ine in aqu eo u s a lka line so lu tion a lone, or w h en ad d ed to serum in- v itro , w ere b e tw een 88 and 103 p e r cen t—add in g th e am ounts found in 1 ml o f serum (1). T riiodo thyro n in e , triio d o th y ro ace tic acid and te tra io d o th y - roacetic acid ad d ed in v itro to serum y ie ld e d recove ries o f io d in e w hich w ere as com ple te as those from thyroxine. H ow ever, w h en triio d o thyron ine in m ain ten an ce doses w as ad m in iste red in v ivo , no increase in th e concentra tion o f serum B E I cou ld b e d e tected . M oreover, w h en as m uch as 32 gam m a p e r 100 m l. o f d iiodotyrosine iod ine or 1,000 gam m a p e r 100 m l. o f inorganic io d in e w as a d d ed in v itro to serum (1), no n e was recovered . In g b ar e t al. (17) in th e ir study o f bu tanol-ex tractab le I 131 found sim ilar p e rcen tile recoveries o f thyroxine I 131 an d virtual exclusion o f th e I 131 lin k ed w ith potassium iod ide or d iiodotyrosine . In our original SPI s tu d ies (3), 84 p e r cen t o f th e iod ine o f d iiodotyrosine was recovered . T hus th e re is a quan tita tively im portan t d iffe rence b e tw ee n th e specificity o f th e B E I as com p a re d w ith th e S P I d e te r m in a tio n . T h e B E I tech n iq u e does no t e lim inate con tam ination from organic iod ine com pounds2 g iven for d iagnostic or th e rap eu tic p u rposes (9).”
2 See A ppendix for essen tia l tech n iq u e in o b ta in ing sera for B E I d e te rm in a tio n s.t
This study was prospective with thyroid replacem ent therapy being provided only to gravidae, not to their progeny
* P ro lo id g e n e ro u s ly d o n a te d by th e W arn e r L am b ert C om pany, M orris Plains, NJ.
t R eproduced w ith perm ission o f J. C lin . E n d o crinol. XVII, 1375, 1957.
230 M AN, BROWN, A ND SERUNIAN
after birth. T-tests dem onstrated no significant differences be tw een the adequately and inadequately treated groups of hypothyroxinémie women in maternal intelligence quotients (T = 1.28 not significant), years of education (T = 0.29 not significant), or chronological ages (T =0.90, not significant).28(VIII,1X)
P sycho log ica l exam inations of the progeny were conducted at the Brown U niversity C hild D evelopm ent Study according to protocols for eight month, four year, and seven year examinations specified by the Collaborative Perinatal P ro jec t. P ro ced u res for a d m in is tration and scoring were as prescribed in th e m a n u a ls o f s p e c i f i c a s s e s s ments.6’7,8,9'10,11,45 At eight months, the mental and motor scales of the research v e rs io n o f th e B ay ley S cales w ere adm inistered.28(v) At four years, the Stan- ford-Binet In telligence Scale, Form L- M,40 as well as fine and gross motor tasks, were adm inistered.28(VII) The W echsler Intelligence Scale for Children (WISC)45 and the B ender Visual-M otor G estalt Test were adm inistered at seven years. All examinations were adm inistered and scored w ithout the exam iner’s know ledge of the thyroid status of the mothe r or th e d e v e lo p m e n ta l h is to ry of the child.28(IX)
R e s u l t s
I n c i d e n c e o f M a t e r n a l H y p o t h y r o x i n e m i a T h r e e P e r c e n t
Figures 1, 2 and 3 are reproduced by courtesy of The C. V. Mosby Company.* In figures 1 and 2 are represented 304 serial, gestational serum BEIs of euthy- roxinemic women aged 35 and over and 24 BEIs six or more weeks after delivery. Outer solid lines show means ± 2 S.D. for 164 serial serum BEIs during pregnancies of 30 control euthyroxinemic women
aged 18 through 34 years.28<I) Shaded areas dem onstrate these values. Graphs for 449 gestational BEIs and 47 values at lea s t six w eeks a fte r d e liv e ry o f 94 younger euthyroxinem ic women showed sim ilar d istr ib u tio n s28*11̂ and are not reproduced here. All pregnancies were uncom plicated with deliveries of living neonates, classified normal, and weighing at least 2500 grams. To summarize: 917 BEIs of euthyroxinem ic pregnant women fell w ithin the gray areas of figures 1 and 2. (For 164 see reference 28(1) and for 753 see reference 28 (II).) In contrast are the BEIs in figure 3 during 39 pregnancies of hypothyroxinemic women before adequate thyro id rep lacem en t therapy .28(v) Scales for m inim um and maximum are p lotted slightly but insignificantly differently. Note the BEIs in figure 3 below the minima of figures 1 and 2. The incidence of hypothyroxinemia as shown in figure 3 illustrates our m eaning of the term hypothyroxinemia and w ill b e co m p ared w ith d a ta of V olpe,4 Solom on,! T u n b rid g e ,41 and Glinoer21 in the discussion. The overall contrast betw een figure 3 and its counterparts, figures 1 and 2, is obvious.
P s y c h o l o g i c a l T e s t s o n P r o g e n y
In table I are m ean developm ental and intelligence quotients of the progeny at eight m onths,28(v) four years,28(VI1) and seven years.28<VII1,IX) At eight months, the m ean developm ental quotients on the mental and motor scales of the Bayley Scales were essentially identical for the infants of the euthyroxinemic and adeq u a te ly t r e a te d h y p o th y ro x in e m ic w om en. Scores of p rogeny o f in ad e q u a te ly t r e a te d h y p o th y ro x in e m ic w om en w ere significantly low er than th o se o f c h i ld r e n o f e u th y r o x in e mic women.28(V,VII’VIII,IX)
Incidence of normal vocabulary and speech at four years among progeny of
* St. Louis, MO. t Personal com m unication to EBM.
MATERNAL HYPOTHYROXINEMIA: PSYCH ONEUROLOGICAL D E FIC ITS O F PROGENY 231
1 2
10-
- 600AEa 4ESo
co
wniMP1 1 . .. . qp iIM>N iÌiS i'Ìm ^ 'ÌiìÌlI'h i!i ’ Ì'i: i iü 1 ; '
1 « , ' * * » ■ , Í
21 Women 35 Years or Over22 Pregnancies
134 BEI during pregnancy 12 BEI post-partum
Gravida 5 or Less• = 2 BEI before 24 weeks x = 1 BEI before 24 weeks
Age 18 to 35 mean ± 2 S.D.
12 1 6 20 2 4 28 32Weeks After Last Menstrual Period
36 40
F i g u r e 1. One hundred thirty-four gestational BEIs and 12 postpartum values of 21 euthyroxinem ic women aged 35 and over and gravida 5 or less relative to 22 pregnancies.281111 Each dot represents a serum BEI determ ined in duplicate. The gray area, minimum and maximum lines, represents the means ± 2 S.D. for 164 serial gestational BEIs of 30 control euthyroxinemic women aged 18 through 34 years during uncomplicated pregnancies.28® They delivered living neonates weighing at least 2500 grams and classified normal by pediatricians trained in neonatology.
a d e q u a te ly t re a te d h y p o th y ro x in ém ie w om en was 71 percen t; am ong progeny of eu thyrox inem ic w om en, 63 percen t; a n d am o n g p ro g e n y o f in a d e q u a te ly trea ted hypothyroxiném ie w om en, 44.5 percent. Almost 75 p ercen t of the progeny of adequate ly trea ted hypothyroxiném ie w om en w ere co n sid ered to have norm al vocabulary and speech, yet less than h a lf o f th e progeny of inadequately trea ted hypothyroxiném ie w om en w ere rated as norm al in these areas.
At four and seven years, the h ighest m ean IQs w ere ob tained by the progeny of adequately trea ted hypothyroxiném ie w o m en w ith th e n e x t h ig h e s t m ean ob ta ined by progeny of euthyroxinem ic w om en and th e low est m ean q u o tien t o b ta in e d by p ro g e n y o f in a d e q u a te ly trea ted hypothyroxiném ie w om en. T he d iffe rence b e tw e en the m ean IQ q uo
tien ts o f the progeny of the two hypothyroxiném ie groups was significant. T was 1.70 and P < 0.05. A m ost rem arkable aspect of tab le I is the stability o f quotien ts am ong the th ree groups o f progeny over tim e and w ith th re e in s tru m en ts o f assessm en t b u t esp ec ia lly th e co n s is ten cy o f q u o tien ts for th e p ro g en y o f a d e q u a te ly t r e a te d h y p o th y ro x in ém ie w om en.
A d istribu tion of the WISC full scale quotien ts at seven years (end o f tab le I) in c lu d ed m ore quo tien ts in th e ranges below 80 and 80 to 109 w ith few er quotien ts in the 110 or m ore range am ong the p rogeny of eu thy rox inem ic and in a d e q u a te ly t r e a t e d h y p o th y r o x in é m ie w om en than expected. T he incidence of quotien ts in the 80 to 109 range for p rogeny of adequately trea ted hypothyroxiném ie w om en w as less th an ex p e c te d
12i
232 MAN, BROWN, A ND SERUNIAN
29 Women 35 Years or Over Gravida 6 to 13 ̂ 30 Pregnancies • = 2 BEI before 24 weeks
170 BEI during pregnancy x = 1 BEI before 24 weeks12 BEI post-partum f. ■" Age 18 to 35 mean ± 2 S.D.
° 8 12 16 20 24 28 32 36 40Weeks After Last Menstrual Period
FIGURE 2. One hundred seventy serial gestational BEIs and 12 postpartum BEIs of 29 euthyroxinemic women aged 35 and over and gravida 6 to 13 relative to 30 pregnancies.28<II) Each dot represents a serum BEI determ ined in duplicate. The gray area, minimum and maximum lines, represents the means ± 2 S.D. (or 164 serial gestational BEIs of 30 control euthyroxinemic women aged 18 through 34 years during uncomplicated pregnancies.28*1' They delivered living neonates weighing at least 2500 grams and classified normal by pediatricians trained in neonatology.
because of the very high incidence of quotients in the 110 or more range. No progeny of adequately treated hypothyroxinémie women obtained a quotient below 80 w hile no progeny of inadeq u a te ly t r e a te d h y p o th y ro x in é m ie wom en obtained a quo tien t of 110 or more. At both four and seven years, progeny of the hypo thyrox iném ie in a d e quately treated women (Group III) were poorest in performance of motor skills.
Three hypothyroxinémie women had two children participating in the study with one born after adequate maternal thyroid treatm ent and one after inadequate thyroid treatm ent.28<IX) Progeny of adequate ly trea ted hypothyroxiném ie pregnancies obtained a mean fullscale IQ at seven years of 103.0 whereas the siblings of inadequately treated pregnancies
obtained a m ean IQ of 83.0. The difference in mean full scale quotients is surprisingly large (more than 1 S.D.) since, in general, siblings tend to have more sim ilar quotients. All progeny of adequately treated pregnancies were classified as overall normal at seven years of age, while none of their siblings were so classified.
P l a c e n t a s
Only weights, not gross and not microscopic examinations, were available for placentas of 31 euthyroxinemic (Group I), of 11 adequately treated hypothyroxinémie (Group II) and of 14 inadequately treated hypothyroxinémie pairs (Group III) as show n in tab le II. P lacen tal weights of Groups I and II ranged from
M ATERNAL HYPOTHYROXINEM IA: PSYCH ONEUROLOGICAL D E FIC IT S O F PROGENY 233
F ig u r e 3. G esta tional B E Is o f 39 hypothyroxiném ie w om en. T h e op en area b e tw een m in im um and m axim um gestational B E Is for eu thy rox inem ie w om en m irrors th e gray areas o f figures 1 and 2 o f gestational B E Is o f eu thy rox inem ie w om en.2® Sym bols on th e B E I de te rm in a tio n s iden tify som e signs or sym ptom s d u rin g 24 o f th e 39 pregnancies. Sym bols are located a t value o f serum B EI. 4-T, P revious thyroidectom y. 3-H , C lin ical hypothyroidism . 10-G, Low TB G (T hese in c lu d ed consecu tive va lues on th e sam e w om en, no t th e in c id en ce o f low TBG s).28<III) 7-R, P rev ious rep ro d u c tiv e d ifficu lties.281 V)
TABLE IPsychological Tests on Progeny
Mean Developmental and Intelligence Quotients at 8 Months. 4 Years, and 7 Years
BayleyD.Q. at 8 Months
Mean MeanBinetl.Q.
at 4 YearsWISC Full
Scale I.Q. a t 7 Years
Distribution o f WISC Full Scale 7 Year I.Q.
NumbersMother Group No. Mental Motor No. Mean No. Mean <80 80-109 >110
Euthyroxinemie 1 242 101 104 227 99.5 210 96.6 21 157 32Hypothyroxinémie adequate therapy II 29 102 104 22 102.0 15 104.5 0 8 7Hypothyroxinémie inadequate therapy III 55 95 98 23 93.0 21 91.9 5 16 0
WISC - Wechsler Intelligence Scale for Children.
234 MAN, BROWN, A N D SERUNIAN
TABLE IIPlacental Weights and Birth Weights
Birth Weiaht Placental Weiaht Birth WeightMother Group No.
MeanGram
RangeGram
MeanGram
S.D. Range Gram Gram
Placental Weight Mean Range
Euthyroxinemic * 1 31 3,226 2,580-4,791 450 + 71.0 334-579 7.17 5.39-10.15Hypothyroxinémie adequate therapy II 11 3,222 2,500-3,997 450 + 72.3 339-550 7.16 5.37-9.10Hypothyroxinémie inadequate therapy III 14 3,266 2,665-4,224 447 + 131.8 273-794 6.84 4.64-10.90
* Euthyroxinemic controls matched as to race, age, and gravida of mother and sex of child, and, if possible, by birth weight.Reproduced by courtesy of C.V. Mosby Co., St. Louis, MO.
339 to 579 grams versus 273 to 794 grams for the inadequately treated hypothyroxinémie maternal-fetal pairs. Two of the placentas in this Group III weighed 616 and 794 grams and exceeded weights of the other 42 placentas. A low Leiter I.Q. of 76 was associated w ith a p lacen ta m ark ed ly h e a v ie r (564 gram s) th an expected for a m ale infant w ith birth weight of 2,665 grams. Any significance of these heavy placentas is still unknown. U nfortunately , gross and m icroscopic exam inations w ere no t ava ilab le for hypothyroxinémie pregnancies with poor outcomes of abortions, stillbirths, prem aturity, and major anomalies.28(VI)
T h ree com m ents ab o u t th e ac tive m etabolism of the placenta are pertinent. In Japan, chorionic villi from human placentas o b ta ined by 12-week induced abortions deiodinated T4 as actively as v illi from fu ll term p la c e n ta s .1 The a u th o rs c o n c lu d e d “ fe to -m a te rn a l exchange of T4 and T3 can be regulated by primary chorionic villi, even prior to com pletion of the placental organ, via d e io d in a tio n o f th ese co m pounds.” 1 Yoshida and Suzuki have written a series
of articles about thyroid hormone concentrations in hum an placentas and have described activity of m onodeiodinase.46
Em erson18<p31) wrote, “The placenta is usually regarded as a conduit through w hich m aternal nu trien ts pass to the fetus, or as a barrier that allows for fetal developm ent in an insu lated environm ent . . . ” . . .“ It is less recognized that th e p la c e n ta is a m e ta b o lic a lly ac tive organ.”
Discussion
I n c i d e n c e o f M a t e r n a l H y p o t h y r o x i n e m i a i n P r e g n a n c y
How many women are hypothyroxiném ie d u r in g th e firs t tr im e s te r and unable to supply T4 to cross the p lacenta? Before the fetal thyroid assumes autonomous functions and when thyroid hormones are essential for early central nervous system developm ent, m aternal hypothyroxinemia could result in neurologic deficits of progeny.
Volpé in evaluation of the total population placed up to three percent in a
MATERNAL HYPOTHYROXINEM IA: PSYCHONEUROLOGICAL D E FIC IT S O F PROGENY 235category of hypothyroid ism.4(p275) “The presence of m inor degrees of hypothyroidism (both m ild and subclinical forms) will always be more common than the overt forms of the disease. The term will also embrace patients with ‘compensated ’ hypothyroidism, i.e., normal circulating thyroid horm one levels w ith high thyroid stim ulating hormones (TSH) values, as well as those with equivocal or slightly low thyroid hormone concentrations and elevated TSH levels.26 Up to th re e p e rc e n t of th e p o p u la tio n can be placed in this category; it is much m o re com m on in fe m a le s a n d has a m u ch h ig h e r in c id e n c e w ith a d vanced age.35’89”4(p275)
Tunbridge made “Cross-sectional comm unity surveys of non-iodine deficient C aucasian com m unities in E ngland .41 T h ree p e rc e n t o f such a p o p u la tio n proved to have biochemical evidence of m inor degrees of thyroid failure as well as autoim m une thyro id itis.” In te rre la tions of m aternal and neonatal thyroid autoimm une disease to congenital hypothyroidism have not been clarified but are being investigated strenuously.2,16
N iswander34 published much quoted data that during pregnancy only 0.9 percent of 20,000 white women and 0.3 percent of 20,000 black patients in the Collaborative Project were hypothyroid. For these data, clinical diagnoses of hypothyroidism w ere req u ired from about 14 m edical centers with variant expertise in thyroidal diagnostics. N iswander him self a d m itte d th a t th o se p e rc e n ts w ere undoubtedly falsely low. As a consultant, one o f us (EBM) worked with the Collaborative Project at National Institutes of H ealth and recognized the defects of N isw ander’s data on thyroid diseases in pregnancy. Davies and Cobin12 em phasized that classical clinical symptoms of thyroid disease are masked in pregnancy. “A high degree of expertise strengthened by biochem ical param eters w ith refer
ence to the normal pregnant ranges have to be carefully evaluated before a therapeutic decision can be m ade.” 12
G linoer and associates21 reported in September, 1990, three percent hypothy- roxinemia in Belgium in areas of marginally low iodine intake.26 Glinoer e t al21 and Burrow ,3 in a covering ed itoria l, a d m it th a t io d in e in ta k e w as n o t extremely low but stress the intricacies of gestational thyroid function. Larsen and M andel29 found in primary hypothyroidism a need for increased thryoxine therapy during pregnancy. Utiger, relative to therapy for hypothyroidism, wrote, “The fact that there are situations such as pregnancy and the postpartum period that necessitate alterations in dosage serves as a rem in d er o f the m u ltip lic ity of extrathyroidal factors that can alter thyroid function .”42(pl27) D avid Solomon wrote in a personal letter “I just do not know [the incidence of hypothyroxin- emia in pregnancy]. The confounder is to what extent pregnancy increases dem and and therefore brings out hypothyroxin- em ia in previously normothyroxinemic but hyper-TSH-emic women. This could bum p it back to three percent. I just do not know the facts on that.”*
At Providence Lying-In Hospital, Man looked for hyperthyroxinem ia and was confounded by the high incidence of low BEIs. Standards for BEI were checked daily and cross checked with quantitative controls. In 1969, 173 of 1,394 clinic pregnancies w ere associated w ith low serum th y rox ine-like io d in es and /o r clinical diagnoses of thyroid underfunc- t io n .28(v) T his excessive p e rc e n ta g e included many m ultigraviada and older women. At that point, any patient with every and/or any possible cause for a low serum thyroxine-like iodine was elim in a ted from the study . I f a low B E I
* Personal com m unication to EBM .
236 MAN, BROWN, A N D SERUNIAN
occurred w hen a patient had a sudden w e ig h t gain or an u p p e r resp ira to ry infection ,28<IV) that low determ ination was classified as a sporadic false value. Only women with two authentic criteria of hypothyroxinemia were included. In 1976, Man and Serunian estim ated that at least th ree p e rcen t o f uncom plica ted pregnancies in private and clinic practice at Providence Lying-In H ospital were h y p o th y ro x in é m ie .28(IX) T h e ir da ta , Volpé’s the published report and letter by V o lp e ,4 co m m u n ity su rv e y s by Tunbridge,4 the reference by Solomon* to “pregnancy’s increasing dem ands” support an incidence of th ree percen t of hypothyroxinemia in otherwise uncomplicated pregnancies.
V i s u a l S p a t i a l D i s a b i l i t i e s
The problem of m aternal transfer of thyroxine through the p lacenta to the fetus pertains not only to the health of the m other and the fetus, bu t also to the future psychoneurological developm ent of the progeny.14
Unlooked for were low scores of some four-year-old progeny of hypothyroxiném ie p re g n a n t m o th e rs a d e q u a te ly treated after 12 or 29 gestational weeks in gross motor tests of line walk and ball catch. O f these 17 children, three had strabismus, two wore glasses, and only 70 percent w ere classified “eyes norm al” though 84 percent and 94 percent of the children in the other two groups were classified “eyes normal.” These hypothyroxinémie women had not registered at the prenatal clinic until 11 or 28 gestational weeks. T heir hypothyroxinem ia was neither recognized nor treated until 12 or 29 weeks. Adequate Proloidt had
* Personal com m unication to EBM . t D o n a ted g en ero u sly by th e W arner L am b ert
Co., M orris P lains, NJ.
been prescribed and the serum BEIs of these mothers were in the normal range for pregnancy after 12 or 29 weeks.28(v)
Irreversible brain damage and mental retardation of hum ans after prolonged thyroid failure during fetal and/or postnata l life h av e b e e n e m p h a s iz e d by D elange in his discussions of fetal in utero thyroid failure.13 Many references to neurological deficits of hypothyroid ch ild ren associate d e lay ed bone age at birth with severe deficiency of thyroid hormones during early or prolonged fetal existence.14
Both Farriaux of Lille, F rance19 and Van Vliet of Brussels43 found screening for congenital hypothyroidism effective in p reven ting m ental retardation , bu t some children exhibited “ m ild abnormalities of perception and coordination a t la te r a g e s .” R o c h ic c io li e t al of T o u lo u se 36 re p o rte d no rm al m en ta l developm ent of hypothyro id ch ild ren d iscovered by sc reen in g and trea ted promptly, but in a m inor degree neurological abnormalities were evident. The Catalan Collaborative Group in Barcelona23 also detailed certain ocular impairm ents, such as strabism us associated with fetal lack of thyroid hormones.
Not only in parts of Europe (France, Spain, Belgium, etc.) bu t also in North America these psychomotor and neuropsychological deficits of children have been found .15’16’22’37’38-33 At the 1989 Annual M eeting of The American Thyroid Association in San Francisco, a special satellite symposium was “Thyroid H orm one in the D eve lo p in g B ra in .” Joanne F. Rovet, Ph.D. (Toronto) spoke about “ N europsychological Studies of T h y r o id H o rm o n e D e f ic ie n c y in H u m an s—W indow s on E a r ly B ra in D e v e lo p m e n t.” S u b s e q u e n tly , she described hypothyroid ch ild ren o lder than infancy bu t who had b een diagnosed and treated and seem ed to have m ild in te llec tual im pairm ents desp ite
MATERNAL HYPOTHYROXINEMIA: PSYCH ONEUROLOGICAL D E FIC IT S O F PROGENY 237n o rm a l IQ s . T h e s e im p a ir m e n t s occurred especially w hen in trau terine thyroid deficiencies were suspected.
In Toronto, thyroid therapy for hypothy ro id ch ild ren was p rev iously at a lower dosage than now used there and in New England. However, many at that 1988 conference in Brussels referred to p sy ch o m o to r p sy c h o lo g ic a l d e fic its in children who, at birth, had delayed b o n e age and w ere thus su sp e c te d to h av e e n d u re d in u te r o th y ro x ine deficiencies.14
In contrast to some doctors in Toronto, M itchell and Klein 32,33 recom m ended higher doses of thyroid for hypothyroid infants. W hen tested at age nine to 10 years, 72 of these patients showed IQs which agreed well with those of their siblings and peers; however, several minor scores were noted, as in the reading comprehension subtotal of the Peabody Individual Achievement Test (PIAT) and the v o cab u la ry s u b te s t o f th e W ISC-R. Delayed bone age at birth was reported for 53 of the 72 children, indicating prenatal hypothyroxinemia.
One of the first persons to advocate the testing of all newborns for hypothyroxinemia, which is now standard practice, was Dr. Man. Screening of thyroid function is urged in all pregnant women as w ell as testing prior to pregnancy in women who have experienced any difficulty in prior pregnancies. Our data indicate that there may be damage to the fetus when a pregnant woman has only a m ild degree of hypothyroxinemia, even though she may appear clinically well. H ence screening is urged not only on newborns but also on pregnant women for hypothyroxinem ia to preven t brain damage in newborns.
A d d en d u m
After th e p ap er was com pleted , R obert Z. Klein, M .D . w rote, “ I w ould ap p rec ia te it i f you w ould re fe r in your lis ted supports to th e transp lacen tal
passage o f thyroxine to m y paper. T h e re fe ren ce is K lein, R. Z.: In u tero p ro tec tion o f th e hypothyro id infant. In : Topics in P ediatrics. Pom erance, H. H. and R ercu, B. B., eds. N ew York, Springer Verlag, 1 9 9 0 , p p . 2 5 - 3 3 .”
References
1. A d a c h i , T., M a e d a , M ., N o m o t o , T., e t a l.: In vitro stu d y o n th y ro id h o r m o n e m e ta b o lis m o f h u m a n p la c e n t a in e a r ly p r e g n a n c y . A s ia - O c e a n ia J. O b s te t . G y n a e c o l. 12:385-393, 1986.
2. B r o w n , R.: A m erican T h y ro id A sso c ia tio n M eeting, San Francisco , 1989, N u m b er T52.
3. B u r r o w , G. N.: T hyro id status in norm al p reg nancy. J C lin . E ndocrino l. M etab. 71:274—275, 1990.
4. B u r r o w , G . N., O p p e n h e i m e r , J. H ., a n d V O L P i, R.: T h yro id F u n ctio n a n d D isease. B urrow, G. N.: T hyro id d iseases in pregnancy , pp. 292-323. V olpe, R.: H ypothyro id ism , pp . 274— 292. P h ilad e lp h ia , W. B. Saunders Co., 1989, pp. 1-335.
5. C a l v o , R., O b r e g o n , M . J., M o r r e a l e d e ESCOBAR, G ., e t al: T h y r o id h o r m o n e e c o n o m y in p r e g n a n t rats n e a r term : A “ p h y s io lo g ic a l” a n im a l m o d e l o f n o n th y r o id a l i l ln e s s . E n d o c r in o lo g y 126:10-16, 1990.
6. C o lla b o ra tiv e S tu d y o f C e re b ra l P a lsy an d O ther N eurological and Sensory D iso rders o f Infancy and C hildhood : M anua l o f D irections fo r E ig h t-M o n th P sycholog ica l E xa m ina tion . U.S. D e p a rtm e n t o f H e a lth , E d u ca tio n an d W elfare, B ethesda, M D , 1-6 , January 1961.
7. C o lla b o ra tiv e S tu d y o f C e re b ra l P a lsy a n d O th er N eurological and Sensory D iso rders o f In fan cy a n d C h ild h o o d : M a n u a l f o r C O L R R esea rch F o rm o f B a y le y S ca le s o f M o to r D e v e lo p m e n t. U .S. D e p a r tm e n t o f H e a lth , E ducation an d W elfare, B ethesda , M D ., 1—6, January 1961.
8. C o lla b o ra tiv e S tu d y o f C e re b ra l P a lsy a n d O ther N eurological and Sensory D iso rders o f In fan cy a n d C h ild h o o d : M a n u a l f o r C O L R R esearch F o rm o f R a y ley Sca les o f M e n ta l D e v e lo p m e n t. U .S. D e p a r tm e n t o f H e a lth , E ducation and W elfare, B ethesda, M D ., 1—15, January 1961.
9. C ollaborative S tudy o f C ereb ra l Palsy, M ental R etardation an d O th e r N eurological an d Sensory D iso rders o f In fancy and C hildhood: 4- Year P sychological E xa m in a tio n M anua l f o r th e M otor Test. U.S. D e p a rtm en t o f H ealth , E ducation and W elfare, B ethesda, M D ., 1—3, D ecem b er 1964.
10. C ollaborative S tudy o f C ereb ra l Palsy, M ental R etardation an d O th e r N eurological an d Sensory D iso rders o f In fancy and C hildhood: 4- Year P sychological E xa m in a tio n M anua l fo r th e A d d itio n a l O bserva tions. U.S. D ep artm en t o f H ealth , E d u ca tio n and W elfare, B ethesda, M D., 1-2, D ecem b er 1964.
238 MAN, BROWN, A N D SERUNIAN
11. C ollaborative Study o f C ereb ra l Palsy, M ental R etardation an d O th e r N eurological and Sensory D iso rd e rs o f In fan c y a n d C h ild h o o d : M a nua ls f o r 7-Year P sycholog ica l E xa m in a tion . U.S. D e p a rtm en t o f H ealth , E du ca tio n an d W elfare , B e th e sd a , M D ., 1 -49 , A u g u st 1966.
12. DAVIES, T. F ., C o b i n , R.: T hyro id d isease in p re g n a n c y a n d th e p o s tp a rtu m p e rio d . Mt. Sinai J. M ed. 52:59-77, 1985.
13. DELANGE, F.: Io d in e n u trition and congenital h y p o th y ro id ism . In : R esearch in C o n g en ita l H y p o th y ro id ism . N ew York, P le n u m P ress , NATO ASI Series, 1989, pp. 173-182.
14. D e l a n g e , F . , F i s h e r , D.A., an d G l i n o e r , D .: R esearch in C ongenita l H yp o th yro id ism , vol. 161. N ew York, L ondon, P lenum Press, NATO ASI Series, 1989, pp. 1—367.
15. D u s s a u l t , J. H.: A ction o f thyro id horm ones on b ra in deve lo p m en t. In: R esearch in C ong e n ita l H yp o th yro id ism . N ew York, P len u m Press, N A TO ASI Series, 1989, pp . 95-1020.
16. D u s s a u l t , J. H .: T h y ro id g ro w th b lo ck in g an tib o d ies an d congen ita l hypothyroid ism . In: R esearch in C ongen ita l H yp o th yro id ism , vol. 161. N A TO ASI S eries , N ew York, P len u m Press, 1989, pp. 135-139.
17. E k i n s , R., S i n h a , A., B a l l a b i o , M., e t al.: Role o f m aterna l carrier p ro teins in the supply o f thyro id horm ones to th e feto-placental un it: E vid en ce o f a fe to -p lacen tal req u irem en t for thy- r o x i n e . I n : R e s e a r c h in C o n g e n i t a l H yp o th yro id ism , vol. 161. N ew York, P lenum Press, NA TO ASI Series, 1989, pp. 45-59.
18. E m e r s o n , C. H.: Role o f th e p lacen ta in fetal thyro id hom eostasis. In: R esearch in C ongenita l H yp o th yro id ism , vol. 161. N ew York, P len um Press , NATO ASI Series, 1989, pp. 31—42.
19. F a r r i a u x , J. P., D h o n d t , J. L ., and L e b e c q , M. F .: In te l le c tu a l ou tco m e in h y p o th y ro id c h ild ren sc reen ed a t b irth . In: R esearch in C ong en ita l H yp o th yro id ism , vol. 161. NATO ASI S eries , N ew York, P len u m P ress , 1989, pp . 253-264.
20. FlSHER, D. A. and POLK, D. H.: M aturation o f thy ro id ho rm one actions. In: R esearch in C ong en ita l H yp o th yro id ism , vol. 161, N ew York, P len u m Press, NATO ASI Series, 1989, pp . 61— 77.
21. G l i n o e r , D ., D e N a y e r , P., B o u r d o u x , P., e t al: R egulation o f m aternal thyro id du rin g p reg nancy. J. C lin E ndocrino l M etab. 71:276-287, 1990.
2 2 . G l ORIEUX, J.: M ental d ev e lo p m en t o f patien ts w ith co n g en ita l hyp o th y ro id ism d e te c te d by screen ing : Q u eb ec experience . In: R esearch in C o n g e n ita l H y p o th y ro id ism , vol. 1 6 1 . N ew York, P len u m Press, NATO ASI Series, 1 9 8 9 , pp. 2 8 1 - 2 8 9 .
23. I b a n e z , L., A l b i s u , M., P o t a u , N., e t al o f th e C atalan C ollaborative G roup. In: R esearch in C o n g e n ita l H y p o th y ro id ism , vol. 161. N ew York, P len u m Press, NATO ASI Series, 1989, p. 345.
2 4 . Kl e e s , M .: In te llec tu a l and neuropsychological
assessm en t o f ch ild ren w ith co n gen ita l hyp o thyro id ism . In: R esearch in C ongen ita l H yp o thyro id ism , N ew York, P len u m Press, NATO ASI Series, 1989, pp. 265—279.
25. LARSEN, P. R.: M aternal th y ro x in e an d cong e n ita l h y p o th y ro id ism . N. E n g l. J . M ed . 321:44-46 , 1989.
26. L a z a r u s , J., H u g h e s , I., H a r p e r , P. e t al.: C ongenita l defects associated w ith congenital h y p o thyro id ism . In : R esearch in C o n g en ita l H yp o th yro id ism , vol. 161. N ew York, P lenum Press, NATO ASI Series, 1989, pp. 157-161.
27. M a n , E. B . and B o n g i o v a n n i , A. M .: T hyro id function in p regnancy an d infancy. M aternal h ypothyroxinem ia and re ta rdation o f progeny. CRC C rit. Rev. C lin . Lab. Sei. 3:203-225, 1972.
28. Ma n , E . B., H e l l e g e r s , A. E ., H o l d e n , R. H., J o n e s , W. S., M e l l it s , E . D ., and Se r u n ia n ,S. A.: T hyro id function in hum an pregnancy . I. T h e significance o f serum bu tanol-ex tractab le io d in es in th e last trim ester. Am. J. O bste t. G y n eco l. 90 :474 , 1964; I I . S e ru m b u ta n o l- ex tractab le iod ine values o f p reg n an t w om en 14 th rough 44 years, Am. J. O bste t. G ynecol. 103:328, 1969; I I I . Serum th y ro x in e-b in d in g p re a lb u m in (TBPA ) a n d th y ro x in e -b in d in g g lo b u lin (TBG) o f p reg n an t w om en a g ed 14 th ro u g h 43 y ears . Am. J. O b s te t. G y n eco l. 103:338, 1969; IV. Serum butano l-ex tractab le iod ine drop w ith w e ig h t gain. Am. J. O bstet. G ynecol. 102:244, 1968; V. In c id en ce o f m aternal serum low butanol-ex tractab le iod ines and o f norm al gestational TBG a n d TBPA capacities. R etardation of 8-m onth-old infants. Am. J. O bstet. G ynecol. 104:898, 1969; VI. P rem atu re d e liv e rie s an d rep ro d u c tiv e fa ilu res o f p reg n a n t w o m e n w i th lo w s e r u m b u t a n o l - extractable iod ines. M aternal serum TB G and TB PA c a p a c itie s . Am. J. O b s te t. G y n e co l. 104:909, 1969; VII. D ev elo p m en t and re ta rdation o f 4-year-old p rogeny of eu th y ro id and of h y p o th y ro x in e m ic w o m e n . Am . J. O b s te t . G ynecol. 109:12, 1971; V III. R e ta rd a tio n o f p rogeny aged 7 years. R ela tionsh ips to m aternal age and m aternal thyro id function. Am. J. O b s te t . G y n e c o l. I l l : 9 0 5 -9 0 6 , 1971 ; IX. D ev elo p m en t or re tardation o f 7-year-old proge n y o f h y p o th y ro x in e m ic w o m e n . A m . J. O bste t. G ynecol. 725:949-957, 1976.
29. M a n d e l , S. J., L a r s e n , P. R., S e e l y , E. W., e t al: In c reased n eed for thyroxine d u rin g p reg nancy in w om en w ith prim ary hypothyroid ism . N. E ngl. J. M ed. 323:91-96, 1990.
30. M o r r e a l e d e E s c o b a r , G.: B rain dam age and thyro id horm one. N eonata l T h yro id Screening. Burrow , G. N. and D ussau lt, J. H ., eds. N ew York, R aven Press, 1980, pp. 25-51 .
31. M o r r e a l e d e E s c o b a r , G., O b r e g o n M . J. and F r a n c i s c o E s c o b a r d e l Re y , F .: T ransfer o f thyro id horm ones from th e m o th er to the fetus. In: R esearch in C ongenita l H y p o th yro id ism , vol. 161. N ew York, P lenum Press, NATO ASI Series, 1989, pp . 15-28.
32. N ew E n g lan d C ongenita l H ypothyro id ism C ollaborative . N eonata l thyro id screen ing : N ow
M ATERNAL HYPOTHYROXINEMIA: PSYCHONEUROLOGICAL D E FIC IT S O F PROGENY 239w e are n ine . In: R esearch in C o n gen ita l H yp o th yro id ism , vol. 161. D e lan g e , F ., ed . N ew York, P len u m Press, NATO ASI Series, 1989, pp. 291-297.
33. N ew E ng lan d C ongenita l H ypothyro id ism C ollaborative: E lem en tary school perform ance of ch ild re n w ith co n g en ita l h y p o th y ro id ism . J. Ped iatr. 116:27-32 , 1990.
34. N i s w a n d e r , K. R . and G o r d o n , M .: The C olla b o ra tiv e P erin a ta l S tu d y o f th e N a tio n a l In s t i tu te o f N eu ro log ic D isease a n d S tro ke . The W om en a n d th e ir Pregnancies. P h ilad e lph ia, W. B. Saunders Co., 1972, pp. 246-247.
35. O r r e g o n , M . J., Ru i z D e O n a , C. R ., F r a n c i s c o E s c o b a r d e l R e y , F . an d M o r r e a l e DE ESCOBAR, G.: R egu la tion o f in trace llu la r thy ro id horm one concen tra tions in th e fetus. In : R esearch in C ongen ita l H y p o th yro id ism , vol. 161. N ew York, P lenum Press, N A TO ASI Series, 1989, pp. 79-94.
36. R o c h ic c io l i , P., A l e x a n d r e , F., and R o g e ,B.: N eu ro log ical d e v e lo p m en t in co n g en ita l h y p o th y ro id ism . In: R esearch in C o n g en ita l H yp o th yro id ism , vol. 161. N ew York, P lenum Press , NATO ASI Series, 1989, pp . 301-308.
37. R o v e t , J. F.: N euro p sy ch o lo g ical s tu d ie s o f thy ro id horm one defic iency in hum ans. W indow s on early b ra in d ev e lo p m en t. S a te llite Sym posium o f th e A m er T hyro id A ssociation A nnual M eeting, San Francisco, Sept. 9, 1989.
38. R o v e t , J., E h r l i c h , R ., a n d S o r b a r a , D.: P re d ic tin g d ev e lo p m en ta l ou tco m e in c h ild re n w ith hy p o th y ro id ism id en tif ie d on n ew b o rn
screen ing . In : R esearch in C o n gen ita l H yp o th yro id ism , vol. 161. N ew York, P len u m Press, NATO ASI Series, 1989, p. 340.
39. SCHUSSLER, G. C.: T h yro x ine-b ind ing P roteins. Thyroid . N ew York, M ary Ann L ieb ert, Inc., P ublishers. 1990, pp . 25-37.
40. TERMAN, L. M . a n d MERRILL, M . A.: S ta n fo rd - R in e t In te llig e n ce Scale . B o s to n , H o u g h to n M ifflin , 1960, pp. 1-349.
41. T u n b r i d g e , W. M. G.: T h e ep id em io lo g y o f hypothyroid ism . C lin E ndocrino l. M etab . 8:21—26, 1979.
42. U t i g e r , R. D .: T herapy o f hypo thyro id ism - W hen are changes n e ed e d ? N. E ngl. J. M ed. 323:126-127, 1990.
43. V a n V l i e t , G ., B a r b o n i , T h ., Kl e e s , M., e t al: T rea tm en t strategy and long term follow up of c o n g en ita l h y p o th y ro id ism . In : R esea rch in C o n g en ita l H y p o th y ro id ism , vol. 161. N ew York, P lenum Press, NATO ASI Series , 1989, pp. 245-252.
44. V u l s m a , T., G o n s , M. H ., and D e V i j l d e r , J. J. M.: M aternal-fetal transfer o f thy rox ine in congenital hypothyro id ism d u e to a total organ ization d efec t o f thyro id agenesis. N. E ngl. J. M ed. 321:13-16, 1989.
45. W e c h s l e r , D .: W echsler In te llig en ce Scale f o r C hildren: M anual. N ew York, T h e Psycholog ical C orporation , 1949, pp. 1—114.
46. Yo s h i d a , K., S u z u k i , M., S k u r a d a , T ., e t al: M easu rem en t o f thy ro id ho rm o n e co n cen tra tions in hum an p lacen ta . H orm . M etabol. Res. 29:130-133, 1987.